Complete this form to register for the CME-certified Ancillary Symposia titled The Future of Cholesterol Management: Application of PCSK9 Inhibitors in Practice.
 
Program Details:
Sunday, March 18, 2018 | McCormick Place South Room S100 A | 5:30 - 7:45 am | Supported by Amgen
Chair: Robert H. Eckel, MD
Faculty: Anne Carol Goldberg, MD, FACP and Henry N. Ginsberg, MD
Patient: Mackenzie Ames, FH Foundation Advocate
 
Agenda:
PCSK9 and the LDL Receptor: Biology and Genetic Underpinnings of Dyslipidemia
Patient Representative Interview
Raising Awareness to Improve Patient Outcomes
Cholesterol Treatment in Diabetes: When to Treat and How
Roundtable Discussion and Audience Questions
*
*